{"id":92442,"date":"2019-06-21T09:42:21","date_gmt":"2019-06-21T16:42:21","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/06\/gensight-biologics-releases-data-cfo-responds-to-leaf-inquiry"},"modified":"2019-06-21T09:42:21","modified_gmt":"2019-06-21T16:42:21","slug":"gensight-biologics-releases-data-cfo-responds-to-leaf-inquiry","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/06\/gensight-biologics-releases-data-cfo-responds-to-leaf-inquiry","title":{"rendered":"Gensight Biologics Releases Data, CFO Responds to LEAF Inquiry"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/gensight-biologics-releases-data-cfo-responds-to-leaf-inquiry.jpg\"><\/a><\/p>\n<p>Gensight Biologics, a company researching \u2013 among other things \u2013 the movement of mitochondrial genetic information to the nucleus to treat hereditary genetic diseases (a strategy that could also have an impact on aging according to the SENS Research Foundation), has recently released data for its latest trial of GS010, a therapy against the blindness-causing genetic disease LHON.<\/p>\n<hr>\n<p>Note: Patrick Deane holds shares in Gensight Biologics (EPA: SIGHT).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gensight Biologics, a company researching \u2013 among other things \u2013 the movement of mitochondrial genetic information to the nucleus to treat hereditary genetic diseases (a strategy that could also have an impact on aging according to the SENS Research Foundation), has recently released data for its latest trial of GS010, a therapy against the blindness-causing [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-92442","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/92442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=92442"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/92442\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=92442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=92442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=92442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}